Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Illumina : Files New Patent Infringement Suit Against Premaitha Health plc

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/07/2017 | 03:04pm CEST

Illumina, Inc. (NASDAQ:ILMN) announced today that the company has filed a new patent infringement suit against Premaitha Health plc in the High Court of Justice, Chancery Division, Patents Court in the United Kingdom. Illumina is seeking all available remedies, including damages and injunctive relief.

The new suit accuses Premaitha’s IONA® Test of infringing European Patent (UK) 1 524 321 B2 titled, “Non-invasive Detection of Fetal Genetic Traits,” which is exclusively licensed to Illumina from Sequenom, Inc.

Illumina and its wholly owned subsidiary, Verinata Health, Inc., previously filed suits in the UK against Premaitha accusing its Iona test of infringing European Patent (UK) 0 994 963 B2, European Patent (UK) 1 981 995 B1, European Patent (UK) 2 183 693 B1, European Patent (UK) 2 385 143 B1 and European Patent (UK) 2 514 842 B1. Those suits remain pending.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.


© Business Wire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ILLUMINA
05/25ILLUMINA : Patent Application Titled "Methods for Chemical Ligation of Nucleic A..
AQ
05/25ILLUMINA : $75,735 Federal Contract Awarded to Illumina
AQ
05/24ILLUMINA INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/24KASKELA LAW LLC : Announces Investigation of Illumina, Inc. on Behalf of Stockho..
BU
05/24ILLUMINA : One (1) year and two (2) option years of the comprehensive maintenanc..
AQ
05/22ILLUMINA : Free Daily Technical Summary Reports on Valeritas and Three Other Med..
AC
05/22ILLUMINA : Report
CO
05/21BRISTOL MYERS SQUIBB : Illumina to Develop Companion Diagnostics for Oncology Im..
AQ
05/21ILLUMINA : J-- Illumina Silver Support Service Contract
AQ
05/17ILLUMINA : $103,051 Federal Contract Awarded to Illumina
AQ
More news
News from SeekingAlpha
05/17INSTITUTIONAL TOP IDEAS SERIES : Opaleye Management 
05/15Illumina buys Edico Genome 
05/04INSTITUTIONAL TOP IDEAS SERIES : Orbimed Advisors 
04/24Illumina's (ILMN) CEO Francis deSouza on Q1 2018 Results - Earnings Call Tran.. 
04/24Illumina Q1 top line up 30%; non-GAAP earnings up 128%; cash flow up 52%; gui.. 
Financials ($)
Sales 2018 3 196 M
EBIT 2018 828 M
Net income 2018 672 M
Finance 2018 1 353 M
Yield 2018 -
P/E ratio 2018 58,93
P/E ratio 2019 52,38
EV / Sales 2018 11,8x
EV / Sales 2019 10,4x
Capitalization 39 134 M
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 273 $
Spread / Average Target 2,5%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive Vice President-Products & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA23.96%39 134
THERMO FISHER SCIENTIFIC12.52%85 956
DANAHER CORPORATION10.15%71 345
INTUITIVE SURGICAL25.44%51 726
BOSTON SCIENTIFIC CORPORATION23.64%41 822
ROYAL PHILIPS13.78%39 823